Use of Voclosporin in Pediatric Patients: A Summary of Available Data from Post-marketing Reports (ACR Convergence 2025) - Sep 15, 2025 - Abstract #2446; Pres time: Oct 28, 2025; 10:30 AM - 12:30 PM; Location: Hall F1; In Person; P3 | "Due to the limited number of reports and incomplete nature of spontaneous reporting, the emerging safety profile of voclosporin in pediatric patients requires further investigation, although no new safety signals were detected. Additional research is needed to better characterize the use of voclosporin in this population.1. Wenderfer SE, et al."
Clinical • P4 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics • Renal Disease • Systemic Lupus Erythematosus
|
|
Eugenia Chock1; Ankana Daga2; Tasim Begum3; Kathryn Dao3; Michelle Dardeno3
|